your prescriber submits the prior authorization OSA pathway: If you have sleep apnea, Part D coverage may be available (see below) TrumpRx: Direct-purchase at ~$346/month via TrumpRx.gov Self-pay: See our cost guide for other options HOW ZEPBOUND MAY BE COVERED The OSA Exception On December 20, 2024 , the FDA approved Zepbound for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity
Indian Journal of Psychological Medicine, 34 (3), 255262
However, the lipoatrophic diabetes observed in patients with lipodystrophies differs significantly from common type 2 diabetes in several regards, typically with significantly reduced adipose mass, dysregulation of adipose derived hormones including leptin and adiponectin, dyslipidaemia, more severe insulin resistance and significant hyperinsulinemia (2, 4, 6)
It says the interval between increases lets the body adapt and gives the provider time to assess side effects